Akanda corp. signs share purchase and escrow agreements for the sale of portuguese assets to somai pharmaceuticals

London, united kingdom--(newsfile corp. - february 29, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announced the signing of a definitive share purchase agreement and escrow agreement with somai pharmaceuticals unipessoal, lda ("somai"), marking a significant milestone in the sale of its portuguese subsidiary, rpk biopharma unipessoal, lda ("rpk"). this strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.
AKAN Ratings Summary
AKAN Quant Ranking